ARAMCHOL Trademark

Trademark Overview

On Thursday, August 9, 2018, a trademark application was filed for ARAMCHOL with the United States Patent and Trademark Office. The USPTO has given the ARAMCHOL trademark a serial number of 88071603. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by Galmed Pharmaceuticals Ltd.. The ARAMCHOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, Fatty Acid Bile Acid Conjugates (FABAC) being medical therapeutics for treatment of liver diseases and fibrosis; pharmaceutical preparations, namely, Fatty Acid Bile Acid Conjugates (FABAC) for the treatment of liver diseases and cholesterol gallstones
aramchol

General Information

Serial Number88071603
Word MarkARAMCHOL
Filing DateThursday, August 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, Fatty Acid Bile Acid Conjugates (FABAC) being medical therapeutics for treatment of liver diseases and fibrosis; pharmaceutical preparations, namely, Fatty Acid Bile Acid Conjugates (FABAC) for the treatment of liver diseases and cholesterol gallstones

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGalmed Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTel Aviv 6473307
IL
Party NameGalmed Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTel Aviv 6473307
IL

Trademark Events

Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 12, 2022PETITION TO DIRECTOR DENIED
Wednesday, October 12, 2022ASSIGNED TO PETITION STAFF
Wednesday, September 28, 202244(e) PETITION - RECEIVED
Wednesday, September 28, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 5, 2022SOU EXTENSION 5 GRANTED
Thursday, March 31, 2022SOU EXTENSION 5 FILED
Tuesday, April 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 31, 2022TEAS EXTENSION RECEIVED
Friday, October 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 29, 2021SOU EXTENSION 4 GRANTED
Wednesday, September 29, 2021SOU EXTENSION 4 FILED
Wednesday, September 29, 2021TEAS EXTENSION RECEIVED
Saturday, March 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 18, 2021SOU EXTENSION 3 GRANTED
Thursday, March 18, 2021SOU EXTENSION 3 FILED
Thursday, March 18, 2021TEAS EXTENSION RECEIVED
Wednesday, September 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2020SOU EXTENSION 2 GRANTED
Monday, September 14, 2020SOU EXTENSION 2 FILED
Monday, September 14, 2020TEAS EXTENSION RECEIVED
Wednesday, April 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 30, 2020SOU EXTENSION 1 GRANTED
Monday, March 30, 2020SOU EXTENSION 1 FILED
Monday, March 30, 2020TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019ASSIGNED TO LIE
Tuesday, June 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 25, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, June 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 25, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, June 25, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, December 27, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 27, 2018FINAL REFUSAL E-MAILED
Thursday, December 27, 2018FINAL REFUSAL WRITTEN
Thursday, December 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 29, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 29, 2018NON-FINAL ACTION E-MAILED
Thursday, November 29, 2018NON-FINAL ACTION WRITTEN
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Thursday, August 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

aramchol acid pharmaceutical treatment liver diseases fabac conjugates namely preparations bile